7.510.27% ( -0.02 )
Delay Trading: Nov 16, 11:25:30Valuation
Current ValuationThe current P/E ratio is 190.75, within the reasonable range, cheaper than 20.34% of the time in the past 5 years, and the industry ranks 155/222, the industry Median 22.14.
190.75xP/E
¥7.53Stock price
¥0.04Earnings per share
190.75xP/E
Stock price¥7.53Earnings per share¥0.04
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 33.24x
- Typical range
- 27.12x–193.28x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.14x
04896144192
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.14x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
600518SHKMYY | 196.78x | -- | ¥17.84B |
688247SHSINOTHERAPEUTICS | 199.11x | -- | ¥3.60B |
002873SZXintian Pharma | 190.75x | -- | ¥1.84B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
